Angiotensin Converting Enzyme 2 (ACE2)
ACE2 is one of the key receptors for SARS-CoV invasion of the human body
[32]. Researchers found that SARS-CoV-infected or recombinant
wild-type SARS-spike protein-treated mice displayed significantly
reduced ACE2 expression in the lung. It has also been shown that the
latest outbreak of coronavirus pneumonia (2019-nCoV, SARS-CoV-2) is
invading human alveolar epithelial cells and is therefore, could be
screened against 2019-nCoV, suggesting further studies [33].